Pay in 4 interest-free payments of $5.45 Learn more
Ships within 48 hours · Estimated delivery Sep 5 - Sep 10
Studies from multiple independent groups across musculoskeletal injury, gastrointestinal disease, vascular injury, and neurological insult have reported positive outcomes
When healthcare innovators work together, we can make sure customer access moves at the same speed as innovation
Key Points: Plaintiffs allege severe, long-term gastrointestinal injuries linked to GLP-1 drugs Novo Nordisk faces claims of inadequate safety warnings Cases are consolidating in federal court as a multidistrict litigation (MDL) Table of Contents The Ozempic lawsuit is one of the fastest-growing areas of mass tort litigation in 2026
Ortega 2011
:max_bytes(150000):strip_icc()/Health-GettyImages-2236560849-a1934f1e4c004a19835cb508d021388b.jpg)
US$ 23.02
US$ 21.53
US$ 25.67
US$ 24.57
